Second malignant neoplasms occuring in survivors of osteosarcoma

Cancer

Volumn 80, Issue 5, 1997, Pages 960-965

  Pratt, Charles B ^a,b   Meyer, William H ^a   Luo, Xiaolong ^a   Cain, Alvida M ^a   Kaste, Sue C ^a   Pappo, Alberto S ^a   Rao, Bhaskar N ^a   Fleming, Irvin D ^a   Jenkins III, Jesse J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Chemotherapy; Epidemiology; Osteosarcoma; Second malignant neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CHONDROSARCOMA; CLINICAL PROTOCOL; COLON CARCINOMA; DRUG MEGADOSE; FAMILIAL CANCER; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RECTUM CARCINOMA; SECOND CANCER; STOMACH CARCINOMA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; FEMALE; FEMUR; HUMANS; INCIDENCE; MALE; METATARSUS; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; RISK FACTORS; SEER PROGRAM; TIBIA; UNITED STATES;

EID: 0030752962     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970901)80:5<960::AID-CNCR19>3.0.CO;2-U     Document Type: Article

References (39)

1. Meadows AT, D'Angio GJ, Mike V, Banfi A, Harris C, Jenkin RD, et al. Patterns of second malignant neoplasms in children. Cancer 1977;40:1903-11.
2. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RD, Marsden B. Second malignant neoplasms in children: an update from the late effects study group. J Clin Oncol 1985;3:532-8.
3. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 1987;56:339-47.
4. Kingston JE, Hawkins MM, Draper GJ, Marsden HB, Kinnier-Wilson LM. Patterns of multiple primary tumors in patients treated for cancer during childhood. Br J Cancer 1987; 56:331-8.
5. Green DM, Zevon MA, Reese PA, Lowrie GS, Gaeta JF, Pearce JI, et al. Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 1994;22:1-10.
6. Nicholson HS, Mulvihill JJ, Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol 1992;20:6-12.
7. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1300-36.
8. Beaty O III, Hudson MM, Greenwald C, Luo X, Fang L, Wilimas JA, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995;13:603-9.
9. Abramson DH, Ellsworth RM, Kitchin FD. Second non-ocular tumors in retinoblastoma. Ophthalmology 1984;91:1352-5.
10. Tucker MA, D'Angio GJ, Boice JD Jr., Strong LC, Li FP, Stovall M, et al. Bone sarcomas linked to radiotherapy and chemotherapy. N Engl J Med 1987;317:588-93.
11. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, Inc., 1980.
12. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Am Statis 1988;16:1141-54.
13. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK. SEER Cancer Statistics Review: 1973-1990. NIH Publication No. 93-2789. Bethesda, MD: National Cancer Institute, 1993.
14. Breslow NE, Day NE. Statistical methods in cancer research. Volume H. Lyon: International Agency for Research on Cancer, 1987.
15. Russo CL, McIntyre J, Goorin AM, Link MP, Gebhardt MC, Friend SH. Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Med Pediatr Oncol 1994;23:354-8.
16. Knowling MA, Basco VE. Breast cancer after treatment for osteosarcoma. Med Pediatr Oncol 1986;14:51-3.
17. Ikeda T, Sekiguchi C, Shimamura K, Ozawa I, Inada T, Hishinuma S, et al. Breast cancer developing after chemotherapy for osteosarcoma: a case report. Jpn J Clin Oncol 1991;21:44-6.
18. Thompson DK, Li FP, Cassady J. Breast cancer in a man 30 years after radiation for metastatic osteogenic sarcoma. Cancer 1979;44:2362-5.
19. Li FP. Second malignant tumors after cancer in childhood. Cancer 1977;40:1899-1902.
20. Ivins JC, Taylor WF, Wold LE. Elective whole-lung irradiation in osteosarcoma treatment: appearance of bilateral breast cancer in two long-term survivors. Skeletal Radiol 1987;16:133-5.
21. Pratt C, Champion JE, Fleming ID, Rao B, Kumar APM, Evans WE, et al. Adjuvant chemotherapy for osteosarcoma of the extremity. Cancer 1990;65:439-45.
22. Di Maio SM, Strong LC, Ford RJ, Ayala AC. Double primary malignancies: osteosarcoma and medulloblastoma. South Med J 1984;77:388-90.
23. Craft AW, Malcolm AJ, Farndon JR. Intestinal leiomyosarcoma following treatment of osteosarcoma in a teenage girl. Pediatr Hematol Oncol 1989;6:341-8.
24. Dewar JM, Courtney JT, Byrne MJ, Joske RA. Esophageal cancer in a young woman after treatment for osteosarcoma. Med Pediatr Oncol 1988;16:287-9.
25. Ozaki T, Sugihara S, Inoue H. Second malignant neoplasms after treatment of osteosarcoma: a report of three cases. Acta Med Okayama 1993;47:129-33.
26. Jacobs AD, Gale RP. Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma. Cancer Treat Rep 1984;68:909-11.
27. Fenaux P, Jouet SP, Bauters F. Translocation t(9;11) (p21:q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs. J Clin Oncol 1987;5:1304-5.
28. Davies SV, Murray JA, Browser-Riley SM. Secondary leukemia with a transformation (8:21)? Cancer Genet Cytogenet 1988;31:271-4.
29. Orazi A, Sozzi G, Morandi F, Rottoli L, Cattoretti G. Acute monoblastic leukemia as a second malignancy following chemotherapy for osteogenic sarcoma: a case report. Pediatr Hematol Oncol 1988;5:39-46.
30. Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, DeVita VT Jr. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 1988;71:403-14.
31. Sozzi G, Miozzo M, Orazi A, Calderone C, Castellano M, Viviani S, et al. Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphoblastic leukemia (t-ANLL). Br J Cancer 1990;61:425-8.
32. Kapelushnik J, Dube I, Wilson P, Greenberg M. Acute lymphoblastic leukemia with t(4;11) translocation after osteogenic sarcoma. Cancer 1991;67:2887-9.
33. Pappo A, Schneider NR, Sanders JM, Buchanan GR. Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma. Cancer 1991;68:1373-5.
34. Jeha S, Jaffe N, Robertson R. Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diammine dichloroplatinum-II-based regimen for osteosarcoma. Med Pediatr Oncol 1992;20:71-4.
35. Mahmud N, Tsukada T, Taniguchi M, Takahasi T, Kihira H, Sekine T, et al. Successful continuous treatment with alltrans retinoic acid for acute promyelocytic leukemia: secondary malignancy after the treatment of osteosarcoma. Intern Med 1994;33:654-7.
36. Miniero R, Barisone E, Vivenza C, Brach delPrevar A, Besenzcon L, Cordero di Montezemelo L, Madon E. Acute lymphoblastic leukemia in a girl treated with osteosarcoma. Pediatr Hematol Oncol 1995;12:185-8.
37. Pui C-H, Rigeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, et al. Acute myeloid leukemia in children treated with epipodophyllo toxins for acute lymphoid leukemia, N Engl J Med 1991;325:1682-7.
38. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borreseri AL, Yah YX, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994;12:925-30.
39. Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol 1990;17:673-82.